MGMT and anaplastic astrocytoma: Wick et al. showed that in patients age 65 years or older with anaplastic astrocytoma or glioblastoma, temozolomide alone was non-inferior to radiotherapy alone; however, in MGMT unmethylated patients, radiotherapy was superior to temozolomide [17].